Connect with us

News

Coronary Stents Market to Rise at 6.1% CAGR; Advent of Micro-sized Stents Will Fuel Demand Forecast till 2025

gbafNews28

The global coronary stents market potential has widened due to recent technological advancements. According to a report published by Fortune Business Insights, titled “Coronary Stents Market Size, Share and Global Trend by Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025,” the market was valued at US$ 5,244.9 Mn in 2017.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065

According to Fortune Business Insights, the market will reach US$ 8,414.5 Mn by the end of 2025, exhibiting a CAGR of 6.1%

Coronary stents possess the ability to enhance severe surgical procedures such as percutaneous coronary intervention (PCI) or angioplasty. The use of coronary stents in regulating the blood supply to the heart has created a huge emphasis on the manufacture of highly efficient products. Coronary stents are inserted into the human arteries to ensure smooth blood supply to the heart. As coronary stents are mostly made up of medical-grade stainless steel, the margin for error is almost zero or minimum.

Coronary stents allow minimally invasive surgical procedures, thereby leading to a huge uptake among end users, globally. Surgical procedures using coronary stents are carried out in a much shorter time and with less discomfort than the procedures such as coronary bypass surgeries. The aforementioned factors will contribute to the growth of the global market and will enable the increase in the global coronary stents market value in the forthcoming years.

Some of the Main Key Players Covered in the Report:

  • Biotronik SE and Co. KG
  • Cardinal Health
  • Cook
  • R. Bard, Inc.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Braun Melsungen AG
  • Abbott
  • Boston Scientific Corporation
  • Medtronic

Get Sample PDF [email protected]

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/coronary-stents-market-100065

Technological Advancements in Products to Enable Coronary Stents Market Growth

Recent product advancements have created a rising uptake of coronary stents in heart-related surgical procedures. In 2018, Medtronic launched a new 2 mm coronary stent for small vessels. The company also announced that it has received approval from the Food and Drug Administration (FDA) or the usage of its latest product. The Resolute Onyx 2.0 was a new drug eluting stent which was introduced as the smallest stent available in the market at the time of its launch. Fortune Business Insights predicts that increasing the introduction of technologically advanced products will favor the growth of the global coronary stents market in the coming years.

Growing Regulatory Approvals Will Lead to Substantial Coronary Stents Market Growth

The high prevalence of coronary arterial diseases has opened up a huge coronary stents market potential. Resulting from the high demand for coronary stents, several companies have shifted their focus on developing technologically advanced stents with the aim of serving a wider audience. The coronary stents market trends such as incorporation of micro-sized stents and use of minimally invasive procedures have contributed to the market growth.

In recent years, regulatory authorities have eased off on their reluctance to approve coronary stents market products. Abbott’s CE approval for Xience Sierra was a game changer in the coronary stents industry as the device received worldwide allocates for its exceptional functional operations. Fortune Business Insights predicts that with Xience, Abbott will account for substantial coronary stents market growth and will encourage other companies operating in the market.Besides Abbott, some of the key players that have contributed to the increase in the coronary stents market size are Medtronic, Terumo Corporation, C. R. Bard, Inc., Cardinal Health, Boston Scientific Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Cook, and Biotronik SE and Co. KG.

More Trending Topics from Future Business Insights:

Dental Implants Market to Value US$ 5725.7 Mn at CAGR of 5.1% by 2026 | Exclusive Report by Fortune Business Insights

Sugar Substitutes Market to Value US$ 10.27 Bn at CAGR of 6.3% by 2026 | Exclusive Report by Fortune Business Insights

Wound Care Devices Market to Value US$ 2,949.2 Mn at CAGR of 5.1% by 2025 | Exclusive Report by Fortune Business Insights

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]

News

Strategy Analytics: Samsung Galaxy S20+ 5G is World’s No.1 5G Smartphone Model by Revenue in H1 2020

gbafNews28

According to the latest research from Strategy Analytics, Samsung Galaxy S20+ 5G was the worlds bestselling 5G smartphone model by revenue in the first half of 2020. Apple iPhone 12 is expected to take the 5G crown in H2 2020.

Ken Hyers, Director at Strategy Analytics, said, Global 5G smartphone industry revenue hit a record US$34 billion in the first half of 2020. Despite coronavirus headwinds, the 5G smartphone market has soared to an all-time high. The 5G engine continues to drive smartphone growth, led by Samsung and Huawei.

Juha Winter, Associate Director at Strategy Analytics, added, Among the 5G smartphone segment, Samsung took 3 of the top 5 positions worldwide in H1 2020. Samsung Galaxy S20+ 5G is the worlds number one bestselling 5G smartphone model by revenue and accounts for a dominant 9 percent share of all 5G smartphone revenues generated worldwide in H1 2020. The S20+ 5G is among the worlds first blockbuster 5G models and is popular across Western Europe, South Korea, North America and elsewhere. Samsungs top-of-the-range S20 Ultra 5G is in 2nd spot and Samsung S20 5G sits in 3rd place. Samsung is making big money from 5G phones.

Ken Hyers, Director at Strategy Analytics, added, Huawei P40 Pro 5G and Huawei Mate 30 5G were the worlds fourth and fifth bestselling 5G smartphone models worldwide in H1 2020. Huaweis 5G smartphones are wildly popular in the giant China market. Looking ahead, we expect Apple iPhone 12 to overtake both Huawei and Samsung during H2 2020. The iPhone 12 5G portfolio will deliver tens of billions of dollars of revenue in just a few weeks during the run-up to the Xmas holiday season and beyond. Apple iPhone 12 will soon take the 5G crown.

The full report, Global Smartphone Shipments, Price & Revenue by Model for H1 2020, is published by the Strategy Analytics Smartphone Model Tracker (SMT) service, details of which can be found here: https://tinyurl.com/yxjptzzr.

Source: Strategy Analytics, Inc.

#SA_Devices

About Strategy Analytics

Strategy Analytics, Inc. is a global leader in supporting companies across their planning lifecycle through a range of customized market research solutions. Our multi-discipline capabilities include: industry research advisory services, customer insights, user experience design and innovation expertise, mobile consumer on-device tracking and business-to-business consulting competencies. With domain expertise in: smart devices, connected cars, intelligent home, service providers, IoT, strategic components and media, Strategy Analytics can develop a solution to meet your specific planning need. For more information, visit us at www.strategyanalytics.com.

Americas Contact:

Ken Hyers / +1 617 614 0757 / [email protected]

EMEA Contact:

Juha Winter / +44 1908 423 626 / [email protected]

Asia Contact:

Woody Oh / +44 1908 423 665 / [email protected]

Continue Reading

News

J.P. Morgan Adds New Features to Newly Branded Liink℠

gbafNews28

Today, J.P. Morgan (NYSE:JPM) unveiled Liink, a new brand name for the firms blockchain-based Interbank Information Network (IIN) and introduced new applications available to Liink participants.

Liink introduced two new applications, Confirm and Format, which were developed from direct feedback of network participants regarding their needs and challenges. Confirm allows for the validation of account information prior to initiating a payment to reduce operating costs related to payment instruction errors and potentially help reduce fraud. Format enables payment instruction validation to check whether a payment message accurately conforms to key country and currency-specific information requirements.

We have been listening to our clients and are delivering solutions with speed, said Christine Moy, the newly appointed Global Head of Liink. Were excited about this next phase of growth and we intend to bring additional next-generation products and services to Liink participants in the coming months.

Liink is an ecosystem and network that enables collaboration, access to new capabilities, and commercialization opportunities for its participants – financial institutions, corporates and fintechs. Originally launched as a pilot in 2017, more than 400 financial institutions and corporations have signed up to become a Liink participant, including 27 of the worlds top 50 banks, representing 78 countries.

Liink is part of Onyx by J.P. Morgan, a new business unit dedicated to building next-generation payment capabilities. Liink as a new brand comes at a pivotal time, as we look to re-architect how money, information and assets move across the globe, said Umar Farooq, CEO of Onyx. As part of Onyx, Liink will continue to leverage the global scale, capital, and expertise of J.P. Morgan.

About J.P. Morgans Corporate & Investment Bank

J.P. Morgans Corporate & Investment Bank is a global leader across banking, markets and securities services. The worlds most important corporations, governments and institutions entrust us with their business in more than 100 countries. With $28 trillion of assets under custody and $634 billion in deposits, the Corporate & Investment Bank provides strategic advice, raises capital, manages risk and extends liquidity in markets around the world. Further information about J.P. Morgan is available at www.jpmorgan.com.

Media Contact:

Jessica Francisco

(212) 270-1719

[email protected]

Continue Reading

News

U.S. Vaccine Allocation Planner for COVID-19 Launched by Ariadne Labs and Surgo Foundation

gbafNews28

When COVID-19 vaccines become available in the United States, there wont be enough to vaccinate everyone right away, and states will need to allocate them to their highest priority populations. A new tool provides state and county decisionmakers the region-specific data they will need to distribute vaccines to different populations based on available vaccine doses, priority populations, and vulnerable communities.

The Vaccine Allocation Planner for COVID-19 was jointly developed by Ariadne Labs, a joint center for health systems innovation at Brigham and Womens Hospital and Harvard T.H. Chan School of Public Health; and Surgo Foundation, a nonprofit focused on solving health and social problems with precision.

The National Academies of Sciences, Engineering, and Medicine (NASEM) recently launched a set of vaccine allocation guidelines for the United States, identifying 13 high-priority populations to be vaccinated in phases:

  • Phase 1A includes high-risk workers in health facilities and first responders.
  • Phase 1B includes people with significant comorbid conditions and people living in congregate care settings.
  • Phase 2 includes critical workers in other high-risk settings (public transit, grocery stores, etc.); teachers and school staff; people with moderate comorbid conditions; all older adults; people in homeless shelters or group homes; and incarcerated people or staff who work in jails.
  • Phase 3 includes young adults; children; and the remaining critical workers.
  • Phase 4 includes anyone residing in the United States who didnt have access to vaccines in prior phases.

The Vaccine Allocation Planner for COVID-19 helps state and county decisionmakers operationalize the NASEM guidelines, allowing users to obtain size estimates of the high-priority populations in their immediate regions and weight purely by this criteria, while also considering other factors like community vulnerability. It also helps users estimate the number of vaccine doses available; and the percentage of vaccine coverage achievable under various scenarios.

State and local leaders are going to need to make decisions about how to distribute their allotted COVID-19 vaccine doses, and there are many permutations those decisions could take, said Dr. Sema Sgaier, Executive Director of Surgo Foundation and adjunct assistant professor at Harvard T.H. Chan School of Public Health. Our tool gives them the concrete, localized data they will need to estimate with precision and maximize the public health impact of the coronavirus vaccine, while at the same time prioritizing vulnerable populations.

“In the midst of the pandemic, we will face a scarce supply of the COVID-19 vaccines. Nations, states and local municipalities are planning for effective vaccine distribution, said Dr. Rebecca Weintraub, Director of Vaccine Delivery at Ariadne Labs and Associate Physician, Division of Global Health Equity at Brigham and Womens Hospital in Boston. “Unfortunately, too often scarce resources go to the most privileged. We built this tool for leaders with the data they will need on available vaccine doses, priority populations, and at risk communities to plan for effective and equitable vaccine distribution.

Our committee laid out a four-phased, evidence based approach to COVID-19 vaccine allocation in the United States, but there will be a number of uncertainties around that allocation that state and local leaders must plan for, said NASEM Committee Co-chair Dr. Helene Gayle, President and CEO of the Chicago Community Trust. This tool helps them do that, providing the most reliable estimates of high-priority populations and allowing them to weigh that data against potential scenarios.

Data for the Vaccine Allocation Planner for COVID-19 were sourced from the U.S. Census Bureaus American Community Survey (ACS), the Bureau of Labor Statistics’ Quarterly Census of Employment and Wages (QCEW), California Office of Emergency Services, CDCs National Health Safety Network (NHSN), Homeland Infrastructure Foundation-Level Data (HIFLD), Clark et al., 2020, and the Vera Institute of Justice.

Access the Vaccine Allocation Planner for COVID-19 at covid19vaccineallocation.org.

About Surgo Foundation

Surgo Foundation, based in Washington, D.C., is a nonprofit organization dedicated to solving health and social problems with precision. We do this by bringing together all the tools available from behavioral science, data science, and artificial intelligence to unlock solutions that will improve and save lives. We work in the United States and in low- and middle-income countries on issues like COVID-19, HIV/AIDS, tuberculosis, maternal mortality, health care, housing, and more.

About Ariadne Labs

Ariadne Labs is a joint center for health systems innovation at Brigham and Womens Hospital and Harvard T.H. Chan School of Public Health. We develop simple, scalable solutions that dramatically improve the delivery of health care at critical moments to save lives and reduce suffering. Our vision is for health systems to deliver the best possible care for every patient, everywhere, every time. Visit ariadnelabs.org to learn more and covid19.ariadnelabs.org to learn about Ariadne Labs response to COVID-19.

Media:

Bethany Hardy, [email protected], 202-277-3848

Brigid Tsai, [email protected], 617-529-8345

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News15 mins ago

U.S. Vaccine Allocation Planner for COVID-19 Launched by Ariadne Labs and Surgo Foundation

When COVID-19 vaccines become available in the United States, there wont be enough to vaccinate everyone right away, and states...

gbafNews28 gbafNews28
News15 mins ago

J.P. Morgan Adds New Features to Newly Branded Liink℠

Today, J.P. Morgan (NYSE:JPM) unveiled Liink, a new brand name for the firms blockchain-based Interbank Information Network (IIN) and introduced...

gbafNews28 gbafNews28
News15 mins ago

Strategy Analytics: Samsung Galaxy S20+ 5G is World’s No.1 5G Smartphone Model by Revenue in H1 2020

According to the latest research from Strategy Analytics, Samsung Galaxy S20+ 5G was the worlds bestselling 5G smartphone model by...

gbafNews28 gbafNews28
News16 mins ago

Global Electron Microscope Market 2020-2024 | Evolving Opportunities with Advantest Corp. and Carl Zeiss AG | Technavio

The electron microscope market is poised to grow by $ 1.22 bn during 2020-2024 progressing at a CAGR of about...

gbafNews28 gbafNews28
News46 mins ago

Electric Vehicle (EV) Charging Station Market New Opportunities | Growing Adoption of BEVs and PHEVs to Boost Growth in the Consumer Discretionary Industry | Technavio

The electric vehicle (EV) charging station market is expected to grow by USD 19.9 billion during 2020-2024, expanding at a...

gbafNews28 gbafNews28
News1 hour ago

Revez Corporation Disrupts Media Industry With Introduction of Mediatech

The company injects experiential innovation into Mediatech landscape with acquisition of PGK Digital Networks SINGAPORE, Oct. 28, 2020 /PRNewswire/ — REVEZ...

gbafNews28 gbafNews28
News1 hour ago

Zendesk and Enterprise Strategy Group report confirms link between customer-centric leadership and business growth in Asia Pacific

New CX Maturity Scale finds companies using service and support best practices drive dramatically better success and agility in the...

gbafNews28 gbafNews28
News1 hour ago

Thirty-Five Outstanding Vietnamese Business Leaders and Organisations Honored at the Asia Pacific Enterprise Awards 2020

‎HO CHI MINH CITY‎, Vietnam, Oct. 28, 2020 /PRNewswire/ — Thirty-five outstanding Vietnamese business leaders and organisations were honored at the...

gbafNews28 gbafNews28
News1 hour ago

Technology and analytics named top investment priority for CFOs in Hong Kong, a joint KPMG and ACCA survey finds

Organisations enhancing digital infrastructure for new flexible working arrangements; Firms on the lookout for talent with diverse skill sets HONG...

gbafNews28 gbafNews28
News1 hour ago

HappyFamily Launches New Nutritious Meal Replacement Product: DrMiow Professor Meal

KUALA LUMPUR, MALAYSIA – Media OutReach – 28 October 2020 – In 2012, HappyFamily is founded by Malaysia’s renowned and outstanding iridology expert– Master Tan....